Literature DB >> 17001236

Transoesophageal echocardiographic evaluation of pulmonary vein anatomy in patients undergoing ostial radiofrequency catheter ablation for atrial fibrillation: a comparison with magnetic resonance angiography.

Gianluca Toffanin1, Virginia Scarabeo, Roberto Verlato, Fabio De Conti, Aldo Antonio Zampiero, Piergiuseppe Piovesana.   

Abstract

OBJECTIVE: A detailed definition of pulmonary vein (PV) anatomy is of great importance in patients undergoing radiofrequency catheter ablation for atrial fibrillation. In fact, it is known that variations in the number and anatomy of the PV ostia are more frequent than thought. The aim of this study was to assess the usefulness of transoesophageal echocardiography (TOE) in defining the exact PV anatomy by comparing it with magnetic resonance angiography (MRA), which is proven to be very accurate.
METHODS: Forty-five consecutive patients (39 male, 6 female, mean age 50 + or - 6 years) affected by drug-refractory atrial fibrillation underwent radiofrequency catheter ablation. They were all studied with MRA and then with TOE in order to exclude intra-atrial thrombi and to assess PV anatomy.
RESULTS: TOE visualised the superior PVs in 100% of cases and the right and left inferior PVs in 98% and 94% of cases, respectively. Only 19 patients (42%) showed typical PV anatomy, with two left and two right distinct PV ostia. In 14 patients (31%), one or two intermediate right PVs and in 12 patients (27%) a common left trunk were detected. The concordance with MRA was high (95%).
CONCLUSIONS: TOE is accurate in assessing PV anatomy and in showing anatomic variations in the PV ostia compared with MRA. Anomalous pulmonary venous drainage is more frequent than expected. TOE can provide functional Doppler information, thus being particularly useful in the follow-up after radiofrequency catheter ablation.

Entities:  

Mesh:

Year:  2006        PMID: 17001236     DOI: 10.2459/01.JCM.0000247322.57536.04

Source DB:  PubMed          Journal:  J Cardiovasc Med (Hagerstown)        ISSN: 1558-2027            Impact factor:   2.160


  7 in total

1.  The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .

Authors:  Tomas G Neilan; Ravi V Shah; Siddique A Abbasi; Hoshang Farhad; John D Groarke; John A Dodson; Otavio Coelho-Filho; Ciaran J McMullan; Bobak Heydari; Gregory F Michaud; Roy M John; Rob van der Geest; Michael L Steigner; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

2.  Evaluation of pulmonary venous variations in a large cohort : Multidetector computed tomography study with new variations.

Authors:  Derya Altinkaynak; Asli Koktener
Journal:  Wien Klin Wochenschr       Date:  2019-06-12       Impact factor: 1.704

3.  Evaluation of pulmonary vein variations and anomalies with 64 slice multi detector computed tomography.

Authors:  Guven Tekbas; Hatice Gumus; Hakan Onder; Faysal Ekici; Cihad Hamidi; Ebru Tekbas; Mehmet Gulicetincakmak; Celal Yavuz; Aslan Bilici
Journal:  Wien Klin Wochenschr       Date:  2011-12-21       Impact factor: 1.704

Review 4.  Preprocedural imaging for patients with atrial fibrillation and heart failure.

Authors:  Wai-ee Thai; Bryan Wai; Quynh A Truong
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 5.  Role of Echocardiography in Atrial Fibrillation Ablation.

Authors:  C Y Andrew; Allan L Klein
Journal:  J Atr Fibrillation       Date:  2011-12-20

6.  Impact of transesophageal echocardiography during transseptal puncture on atrial fibrillation ablation.

Authors:  İsmail Erden; Emine Çakcak Erden; Ebru Golcuk; Tolga Aksu; Kıvanç Yalin; Tümer Erdem Güler; Kazım Serhan Özcan; Burak Turan
Journal:  J Arrhythm       Date:  2016-01-28

Review 7.  Advancements in Imaging for Atrial Fibrillation Ablation: Is There a Potential to Improve Procedural Outcomes?

Authors:  Edmond Obeng-Gyimah; Saman Nazarian
Journal:  J Innov Card Rhythm Manag       Date:  2020-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.